Managing Muscle Weakness, Lifestyle, and Pregnancy
At a Glance
Because Andersen-Tawil syndrome can cause weakness when potassium is low, normal, or high, people should not self-treat with potassium. A clinician-approved plan, careful medication monitoring, trigger tracking, and coordinated heart and pregnancy care are essential.
Managing the neuromuscular side of Andersen-Tawil Syndrome (ATS) requires a very different approach than other forms of periodic paralysis. Because the potassium “glitches” in ATS are unique, what works for others might not work—or could even be risky—for you. The goal is to identify your personal patterns and work with a specialist to find the right balance of medication and lifestyle adjustments [1][2].
The Potassium Paradox
In most conditions, “periodic paralysis” is labeled as either hypokalemic (low potassium) or hyperkalemic (high potassium). However, ATS is a “potassium paradox”: weakness can happen when your blood potassium levels are low, normal, or even high [3][4].
- Do Not Improvise: It is a critical safety rule in ATS that you follow a clinician-approved written plan; do not take extra supplements on your own without medical guidance, and if severe, do not delay emergency care while seeking a test result [4][3].
- The Danger of “Automatic” Potassium: If your weakness is happening while your potassium is already high, taking more potassium can be dangerous for your heart rhythm [4].
- Individualized Response: Only about half of people with ATS (roughly 53%) have low potassium during an attack [3]. Your doctor will help you determine your specific “attack profile” based on tests taken during an episode [5]. And as a reminder, weakness can happen whether potassium is low, normal, or high [6].
Medications for Muscle Weakness
If lifestyle changes aren’t enough to manage frequent attacks, your neurologist may suggest a type of medication called a carbonic anhydrase inhibitor. These drugs help the body maintain a stable internal environment that makes muscle cells less likely to become paralyzed.
- Acetazolamide: This is often used for ATS. In a large observational cohort, about 67% reported a good neuromuscular response, though response is variable [1].
- Dichlorphenamide: While mostly studied in other types of periodic paralysis, it is sometimes used for ATS when acetazolamide isn’t effective, though ATS-specific evidence is much more limited [7][8].
- Monitoring Side Effects: These medications can cause side effects like paresthesia (tingling in the hands and feet), “brain fog,” or a change in how carbonated drinks taste [8][9]. They carry clinically important risks of metabolic acidosis and kidney stones. Long-term use requires regular blood tests to check your electrolytes, bicarbonate, and kidney function [1].
Daily Life and Triggers
While everyone’s triggers are different, certain factors are commonly reported by the ATS community. Keeping a symptom diary can help you and your doctor spot these patterns [3].
- The “Post-Exercise” Window: Weakness rarely hits while you are moving. It most often occurs during the rest period immediately following strenuous activity [3][6].
- Carbohydrate Loads: Large, sugary, or starchy meals can cause a shift in potassium that may trigger an attack [3].
- Immobility: Sitting or lying in one position for too long can lead to stiffness or “focal” weakness in those specific muscles [3].
Pregnancy and ATS
If you are planning a pregnancy, it is important to know that pregnancy in ATS requires specialized care and careful medication review before conception [10][11]. Because pregnancy and delivery put extra stress on the heart and change your body’s chemistry, careful planning is required.
- The Cardio-Obstetric Team: You must be followed by a multidisciplinary team involving a maternal-fetal medicine specialist, an electrophysiologist, and a pediatrician [11].
- Arrhythmia Monitoring: Heart rhythm issues in ATS can be unpredictable during pregnancy. While some women feel better, others may see an increase in “extra beats” or palpitations, especially during the stress of labor or in the weeks after giving birth [12][10].
- Labor and Delivery: Pain management and labor monitoring are highly individualized based on maternal risk [12][11][13].
- Breastfeeding: Every medication must be reviewed separately for fetal and infant effects; do not stop abruptly, but allow your team to guide your postpartum and lactation care [10].
Common questions in this guide
Can Andersen-Tawil syndrome cause weakness when potassium is normal?
What medicines are used for muscle weakness in Andersen-Tawil syndrome?
What can trigger an Andersen-Tawil syndrome attack?
How is pregnancy managed with Andersen-Tawil syndrome?
What monitoring is needed when taking ATS medicines?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.During my last weakness attack, was my potassium low, normal, or high, and how should that result change our home treatment plan?
- 2.If we consider acetazolamide or dichlorphenamide, what side effects (like tingling or brain fog) should I watch for, and how will we monitor my kidney function?
- 3.Is it safe for me to exercise, and what is the best way to handle the 'rest period' afterward to prevent weakness?
- 4.Can we create a written 'Emergency Potassium Protocol' that I can show to ER doctors so they know not to give or withhold potassium without testing first?
- 5.For pregnancy planning: Who will be on my 'cardio-obstetric' team, and what is the plan for monitoring my heart rhythm during labor and after delivery?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
Vivekanandam V, Männikkö R, Skorupinska I, et al.
Brain : a journal of neurology 2022; (145(6)):2108-2120 doi:10.1093/brain/awab445.
PMID: 34919635 - 2
Diagnostic and therapeutic challenges in Andersen-Tawil syndrome.
Jacobsen SB, van der Werf C, van der Kooi AJ, et al.
Heart rhythm 2026; doi:10.1016/j.hrthm.2026.09.020.
PMID: 42754000 - 3
Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.
Villar-Quiles RN, Sternberg D, Tredez G, et al.
European journal of neurology 2022; (29(8)):2398-2411 doi:10.1111/ene.15369.
PMID: 35460302 - 4
Mechanisms underlying the distinct K+ dependencies of periodic paralysis.
Foy BD, Dupont C, Walker PV, et al.
The Journal of general physiology 2025; (157(3)) doi:10.1085/jgp.202413610.
PMID: 39903205 - 5
Clinical, myopathological, and genetic features of two Chinese families with Andersen-Tawil syndrome.
Wang J, Qu Q, Zheng X, et al.
Frontiers in neurology 2024; (15()):1423320 doi:10.3389/fneur.2024.1423320.
PMID: 39359869 - 6
Potassium-sensitive loss of muscle force in the setting of reduced inward rectifier K+ current: Implications for Andersen-Tawil syndrome.
Elia N, Quiñonez M, Wu F, et al.
Proceedings of the National Academy of Sciences of the United States of America 2025; (122(13)):e2418021122 doi:10.1073/pnas.2418021122.
PMID: 40138348 - 7
Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
Gupta A, Iyadurai S, Roggenbuck J, LoRusso S
Neuromuscular disorders : NMD 2021; (31(7)):656-659 doi:10.1016/j.nmd.2021.04.001.
PMID: 34078557 - 8
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.
Sansone VA, Burge J, McDermott MP, et al.
Neurology 2016; (86(15)):1408-1416 doi:10.1212/WNL.0000000000002416.
PMID: 26865514 - 9
Dichlorphenamide: A Review in Primary Periodic Paralyses.
Greig SL
Drugs 2016; (76(4)):501-7 doi:10.1007/s40265-016-0559-2.
PMID: 26941026 - 10
Successful treatment of arrhythmia with β-blocker and flecainide combination in pregnant patients with Andersen-Tawil syndrome: A case report and literature review.
Rujirachun P, Junyavoraluk A, Pithukpakorn M, et al.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2021; (26(3)):e12798 doi:10.1111/anec.12798.
PMID: 32959505 - 11
Perinatal Management of Andersen-Tawil Syndrome Using a Wearable Cardioverter-Defibrillator: A Case Report.
Sakaguchi Y, Otsuki S, Izumi D, et al.
The journal of obstetrics and gynaecology research 2026; (52(1)):e70181 doi:10.1111/jog.70181.
PMID: 41482511 - 12
Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
Inagaki M, Tatsumi T, Yomogita H, et al.
The journal of obstetrics and gynaecology research 2021; (47(1)):446-451 doi:10.1111/jog.14553.
PMID: 33205612 - 13
General anesthesia using propofol infusion for implantation of an implantable cardioverter defibrillator in a pediatric patient with Andersen-Tawil syndrome: a case report.
Park S, Heo W, Shin SW, et al.
Journal of dental anesthesia and pain medicine 2023; (23(1)):45-51 doi:10.17245/jdapm.2023.23.1.45.
PMID: 36819605
This page is for informational purposes only and does not constitute medical advice about Andersen-Tawil syndrome. Medication, potassium decisions, exercise, and pregnancy planning should be individualized with your neurologist, cardiologist, and pregnancy-care team.
Get notified when new evidence is published on Andersen-Tawil syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.